Ross Haghighat Chinook Therapeutics, Inc. (KDNY) insider trading activity
Ross Haghighat is Director of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 124,546 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on May 26, 2023, when has been sold 3,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
125K
0%
3M change
0%
12M change
Total Value Held
$0
RH
Ross Haghighat
Director
Seattle, WA